Similar Search Results

Accelerating vaccine innovation for emerging infectious diseases via parallel discovery

Barberio, Joseph; Becraft, Jacob; Ben Chaouch, Zied; … - In: Entrepreneurship and innovation policy and the economy … 2 (2023), pp. 9-39

Persistent link: https://www.econbiz.de/10015049952

Risk-sharing in pharmaceutical R&D collaborations : the case of out-licensing

Reepmeyer, Gerrit - 2005

Persistent link: https://www.econbiz.de/10003186500

Patents, Partnerships, and the Pre-Competitive Collaboration Myth in Pharmaceutical Innovation

Vertinsky, Liza - 2015

Public-private partnerships offer a promising alternative paradigm for pharmaceutical innovation in complex disease … essential to accelerate pharmaceutical innovation. Patents threaten the potential of partnership strategies, however, by making … innovation is fundamentally flawed for two reasons. First, it ignores the competitive market pressures that both shape what is …

Persistent link: https://www.econbiz.de/10014136820

The rise of spin-offs : fueling pharmaceutical innovation through collaboration

Yashiro, Kentaro; Lim, Yeongjoo; Sengoku, Shintaro; … - In: Journal of open innovation : technology, market, and … 10 (2024) 1, pp. 1-11

Collaboration among various organizations is important for the sustainable creation of new innovative drugs. Previously, drug discovery was dominated by large pharmaceutical companies; however, various new players are now actively involved in this endeavor. Nevertheless, the factors affecting...

Persistent link: https://www.econbiz.de/10014518795

The impact of R&D cooperations on drug variety offered on the market : evidence from the pharmaceutical industry

Banerjee, Tannista; Siebert, Ralph - 2014

Our study puts special attention to the fact that R&D cooperations in the pharmaceutical industry are formed at different stages throughout the drug development process. We study if the timing to engage in R&D cooperations in the pharmaceutical industry has different impacts on the technology...

Persistent link: https://www.econbiz.de/10010229875

Kim, Keungoui; Lee, Junmin; Hwang, Junseok; Kim, Eungdo - In: The journal of product innovation management : an … 39 (2022) 4, pp. 559-580

Persistent link: https://www.econbiz.de/10013332997

Public-private collaboration, hybridity and social value : towards new theoretical perspectives

Quélin, Bertrand V.; Kivleniece, Ilze; Lazzarini, Sergio - In: Journal of management studies : JMS 54 (2017) 6, pp. 763-792

Persistent link: https://www.econbiz.de/10011786692

How does basic research improve innovation performance in the world's major pharmaceutical firms?

Leten, Bart; Kelchtermans, Stijn; Belderbos, René - In: Industry and innovation 29 (2022) 3, pp. 396-424

Persistent link: https://www.econbiz.de/10013170079

Big Pharma, little science? : a bibliometric perspective on Big Pharma's R&D decline

Rafols, Ismael; Hopkins, Michael M.; Hoekman, Jarno; … - In: Technological forecasting & social change : an … 81 (2014), pp. 22-38

Persistent link: https://www.econbiz.de/10010403289

Partnership and innovation in the pharmaceutical industry : the case of clinical research

Ippoliti, R.; Ramello, Giovanni B.; Scherer, Frederic M. - In: Economics of innovation and new technology 30 (2021) 3, pp. 317-334

Persistent link: https://www.econbiz.de/10012498349

1
2
3
4
5
6
7
8
9
10
Next
Last